Pacira Pharmaceuticals (PCRX) Company Statistics | The Fly

Search...

/

Dashboard

Charting

KPIs

Stock Screener

ETF Screener

Earnings Calendar

Events Calendar

Syndicate

Street Research

Portfolios

Alert Settings

Pacira Pharmaceuticals (PCRX) Company Statistics | The Fly

© 2026 The Fly Inc.

The Fly Cast

Press play to listen

©

Pacira Pharmaceuticals

· PCRX

Dashboard

Financials

Ratios

Transcripts

Valuation

Statistics

1.022 B

-2.34%

General

Market Cap: $1.02B
Enterprise Value: $1.19B
Shares Outstanding: 39,350,000
Dividend: —
Employees: —
Revenue Per Employee: —

Fundamental Ratios (TTM)

Gross Margin: 79.21%
Operating Margin: 2.47%
Net Profit Margin: 1.96%
FCF Margin: 24.06%
ROA: 1.18%
ROE: 2.13%
ROIC: 1.35%
Current Ratio: 5.04
Debt-to-Equity: 0.61
Revenue Per Employee: —

Valuation (TTM)

P/E: 67.53
PEG: 7.57
P/S: 1.32
P/FCF: 5.49
P/B: 1.47
EV/EBITDA: 10.38

Growth

Rev 1Y: 3.63%

Income Statement (TTM)

Revenue: $746.16M
Gross Margin: 79.21%
Operating Expenses: $572.57M
Operating Income: $18.45M
Net Profit: $14.64M

Balance Sheet

Rev 1Y Fwd Est

3.85%

Rev 3Y (CAGR)

2.89%

Rev 5Y (CAGR)

11.07%

Rev 10Y (CAGR)

11.30%

EPS 1Y

—

EPS 1Y Fwd Est

1706.74%

EPS 3Y (CAGR)

-22.22%

EPS 5Y (CAGR)

-45.51%

EPS 10Y (CAGR)

14.87%

Cash and Equivalents: $205.88M
Working Capital: $493.2M
Total Assets: $1.24B
Net Debt: $206.24M
Total Liabilities: $572.01M
Total Equity: $671.98M

Cash Flow Statement (TTM)

Cash Flow from Operations: $187.66M
Cash Flow from Investing: $94.15M
Cash Flow from Financing: -$376.18M
Free Cash Flow: $179.52M
Capital Expenditures: $8.15M